The Food Drug Administration is meeting this week to consider giving half doses of Moderna’s COVID-19 vaccine to people ages 18-55.
The head of the Food and Drug Administration says that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after it won the key endorsement of a government advisory panel.
A Food and Drug Administration panel is set to meet Thursday to discuss Moderna’s COVID-19 vaccine, and if they’ll give it emergency authorization.
After the successful rollout of Pfizer’s coronavirus vaccine, the Food and Drug Administration said its preliminary analysis confirmed the effectiveness and safety of the vaccine developed by Moderna and the National Institutes of Health.
This January, you will be able to buy a COVID-19 test to take home.
There is hope on the horizon tonight as the Food and Drug Administration’s advisory panel has officially recommended the Pfizer vaccine for emergency use.
On Thursday, an advisory committee to the Food and Drug Administration recommended approving the Pfizer BioNTech vaccine.
The Food and Drug Administration has granted an emergency use authorization for the first non-prescription, over-the-counter COVID-19 test kit for at-home use.
The Food and Drug Administration is meeting today for a public hearing that could determine whether Americans can begin getting immunized for COVID-19 in a matter of days.
U.S. health regulators have posted a positive review of Pfizer’s COVID-19 vaccine as they near a decision on whether to allow use of the shot.